Showing 161 - 180 results of 1,716 for search '"Tenofovir"', query time: 0.11s Refine Results
  1. 161
  2. 162

    Nuevos tratamientos para el manejo de la Hepatitis B by Federico Salom-Macaya

    Published 2008-11-01
    Subjects: “…tenofovir…”
    Get full text
    Article
  3. 163
  4. 164
  5. 165

    Real-World Analysis of Weight Gain and Body Mass Index Increase Among Patients with HIV-1 Using Antiretroviral Regimen Containing Tenofovir Alafenamide, Tenofovir Disoproxil Fumarate, or Neither in the United States by Bruno Emond, Carmine Rossi, Rachel Rogers, Patrick Lefebvre, Marie-Hélène Lafeuille, Prina Donga

    Published 2022-02-01
    “…**Background:** While some studies among patients with HIV-1 suggest that antiretroviral therapy (ART) regimens containing tenofovir alafenamide (TAF) may be associated with greater weight gain than those not containing TAF, no studies have assessed the relationship between TAF doses and weight change. …”
    Get full text
    Article
  6. 166

    Influence of hepatic steatosis on the outcomes of patients with chronic hepatitis B treated with entecavir and tenofovir by David Sooik Kim, Mi Young Jeon, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Seung Up Kim

    Published 2019-09-01
    “…Methods A total of 334 patients who were initiated on entecavir or tenofovir between 2007 and 2016 with available TE results were recruited. …”
    Get full text
    Article
  7. 167
  8. 168
  9. 169
  10. 170
  11. 171
  12. 172
  13. 173

    Cost-effectiveness of two antiviral therapies for chronic hepatitis B in Peru: entecavir and tenofovir by Rafael Bolaños-Díaz, Romina A. Tejada, César Sanabria, Seimer Escobedo-Palza

    Published 2017-10-01
    “…To compare in terms of cost-effectiveness to entecavir (ETV) and tenofovir (TDF) in the treatment of hepatitis B virus (HBV) in public hospitals in Peru. …”
    Get full text
    Article
  14. 174
  15. 175
  16. 176
  17. 177
  18. 178

    Failure of pre-exposure prophylaxis with daily tenofovir/emtricitabine and the scenario of delayed HIV seroconversion by Shui-Shan Lee, Peter L. Anderson, Tsz-Ho Kwan, Grace C.Y. Lui, Denise P.C. Chan, Ngai-Sze Wong, Krystal C.K. Lee, Teddy T.N. Lam

    Published 2020-05-01
    “…Failure of pre-exposure prophylaxis (PrEP) with tenofovir disoproxil fumarate and emtricitabine may occur despite perfect adherence, although this is uncommon. …”
    Get full text
    Article
  19. 179
  20. 180